MedTrace Logo

Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic Foot

NCT01216865 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2010-10-13

No results posted yet for this study

Summary

The purpose of this study is to determine whether umbilical cord Mesenchymal Stem Cells of treatment for diabetic foot is safe and effective in the management of diabetic foot ischemia, the therapeutic effect of stem cells is caused by improving blood circulation in ischemic limb which would in turn promote ulcer healing, prevent amputation of limb and relieve the Sevier pain of ischemia.

Conditions

  • Diabetic Foot
  • Critical Limb Ischemia
  • Mesenchymal Stem Cells
  • Umbilical Cord

Interventions

BIOLOGICAL

umbilical cord mesenchymal stem cells

5\*10/7 per ischemic limb

DRUG

Standard Therapy

Any thing directed to improve blood perfusion in the limb example.Heparin,Antiplatelet agents etc

Sponsors & Collaborators

  • Qingdao University

    lead OTHER

Principal Investigators

  • Yangang Wang, MD Phd · The Affiliated Hospital of Qingdao University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-12-31
Completion
2013-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01216865 on ClinicalTrials.gov